(0.16%) 5 215.00 points
(0.16%) 39 058 points
(0.01%) 18 198 points
(-0.48%) $78.10
(-0.77%) $2.18
(-0.09%) $2 329.20
(0.28%) $27.69
(1.88%) $983.00
(-0.04%) $0.928
(0.32%) $10.86
(0.07%) $0.796
(-0.06%) $91.29
-2.68% $ 3.63
@ $6.23
Wydano: 14 vas. 2024 @ 22:20
Zwrot: -41.73%
Poprzedni sygnał: vas. 14 - 17:48
Poprzedni sygnał:
Zwrot: -7.02 %
Live Chart Being Loaded With Signals
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine...
Stats | |
---|---|
Dzisiejszy wolumen | 194 224 |
Średni wolumen | 310 295 |
Kapitalizacja rynkowa | 20.01M |
EPS | $0 ( 2024-05-06 ) |
Następna data zysków | ( $-2.20 ) 2024-05-28 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.190 |
ATR14 | $0.0150 (0.41%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-12 | Cr Group L.p. | Buy | 1 647 315 | Common Stock |
2024-04-12 | Cr Group L.p. | Buy | 390 142 | Common Stock |
2024-04-12 | Cr Group L.p. | Buy | 682 036 | Common Stock |
2024-04-12 | Cr Group L.p. | Buy | 424 716 | Common Stock |
2024-04-12 | Cr Group L.p. | Buy | 136 409 | Common Stock |
INSIDER POWER |
---|
3.68 |
Last 99 transactions |
Buy: 52 592 861 | Sell: 43 240 632 |
Wolumen Korelacja
T2 Biosystems Inc Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
COLB | 0.924 |
CBAN | 0.923 |
CARA | 0.92 |
CBLI | 0.914 |
ARQT | 0.9 |
CSSE | 0.893 |
CSF | 0.891 |
FMBH | 0.889 |
FRST | 0.889 |
DNLI | 0.887 |
10 Najbardziej negatywne korelacje | |
---|---|
OFLX | -0.906 |
BLPH | -0.906 |
BCYP | -0.867 |
MNDY | -0.863 |
BNIXU | -0.857 |
SVFC | -0.857 |
INTA | -0.856 |
ASLN | -0.854 |
MKGI | -0.851 |
AZRX | -0.85 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
T2 Biosystems Inc Korelacja - Waluta/Towar
T2 Biosystems Inc Finanse
Annual | 2023 |
Przychody: | $7.19M |
Zysk brutto: | $-8.83M (-122.74 %) |
EPS: | $-19.19 |
FY | 2023 |
Przychody: | $7.19M |
Zysk brutto: | $-8.83M (-122.74 %) |
EPS: | $-19.19 |
FY | 2022 |
Przychody: | $22.31M |
Zysk brutto: | $1.17M (5.23 %) |
EPS: | $-1 242.48 |
FY | 2021 |
Przychody: | $28.06M |
Zysk brutto: | $7.36M (26.21 %) |
EPS: | $-20.29 |
Financial Reports:
No articles found.
T2 Biosystems Inc
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine. The company also offers T2Dx Instrument, a bench-top instrument that runs various diagnostic tests from patient samples; T2Candida, a direct-from-blood test that identifies blood stream infections that causes sepsis and candidemia; T2Bacteria, a direct-from-blood test, which detects bacterial pathogens associated with sepsis; T2Resistance to identify carbapenem resistance genes; and T2SARS-CoV-2 panel to detect SARS-CoV-2 virus. In addition, it is developing T2Biothreat for detection of biothreat pathogens; comprehensive sepsis panel to detect bloodstream infections caused by bacterial and Candida species, and antibiotic resistant markers; T2Cauris to provide direct detection of the emerging superbug Candida auris in patient skin, patient blood, and hospital environmental samples; and T2Lyme, a direct-from-blood test panel designed to run on the T2Dx Instrument to identify the bacteria that cause Lyme disease. The company has collaboration agreements with Canon U.S. Life Sciences, Inc. to develop a diagnostic test panel to detect Lyme disease. T2 Biosystems, Inc. was incorporated in 2006 and is headquartered in Lexington, Massachusetts.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej